Journal
SCIENCE
Volume 290, Issue 5498, Pages 1959-1962Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.290.5498.1959
Keywords
-
Categories
Ask authors/readers for more resources
Genetic engineering of non-beta cells to release insulin upon feeding could be a therapeutic modality for patients with diabetes. A tumor-derived K-cell line was induced to produce human insulin by providing the cells with the human insulin gene linked tb the 5'-regulatory region of the gene encoding glucose-dependent insulinotropic polypeptide (GIP). Mice expressing this transgene produced human insulin specifically in gut K cells. This insulin protected the mice from developing diabetes and maintained glucose tolerance after destruction of the native insulin-producing beta cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available